Time to Decision and Treatment With tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit [Brief Report]

Conclusions—Assessment by a TM-VN is comparable with an OB-VN in making decisions about tPA administration on an MSU and does not lead to treatment delays.Clinical Trial Registration—URL: https://www.clinicaltrials.gov. Unique identifier: NCT02190500.

http://stroke.ahajournals.org/content/49/6/1528.short?rss=1

Source: Stroke - May 25, 2018 Category: Neurology Authors: Ritvij Bowry, Stephanie A. Parker, Jose-Miguel Yamal, Hyunsoo Hwang, Savitri Appana, Nicole Rangel-Gutierrez, Tzu-Ching Wu, Suja S. Rajan, James C. Grotta Tags: Cerebrovascular Disease/Stroke, Ischemic Stroke Brief Reports Source Type: research